Abbvie Inc
NYSE: ABBV
$165.50
-$0.78 (-0.5%)
Real Time Data Delayed 15 Min.
ABBV Articles
Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim CEO and chairman do not seem like serious candidates for the job.
Published:
Last Updated:
Baxter International is taking an activist investor role of its own. The health care company has announced that it is splitting itself into two separate companies.
Published:
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis, of the top health care stocks to buy now. Investors concerned about the toppy market may want...
Published:
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to outperform for the balance of 2014. Here are some of the top health care names to buy now...
Published:
In Deutsche Bank's monthly quant view research piece, the firm looks for strategies that investors can implement to limit their exposure to emerging markets during this period of high uncertainty.
Published:
If one firm can create interest around a stock, it is Goldman Sachs. Investors have followed its Conviction Buy List for years, but 24/7 Wall St. has tracked many major changes to this prized list in...
Published:
Last Updated:
GS.COMIt is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews vast numbers of research reports looking for the best stocks to buy and...
Published:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013. They include Apple, 3D Systems, Micron Technology and Tesla Motors.
Published:
Jon OggWe are in the thick of earnings season, a deal was made in D.C. and stocks are challenging new all-time highs almost daily. So how do investors know which stocks to buy and which ones to sell?...
Published:
ThinkstockThe saying is that if there is a trading strategy, then there is an ETF strategy for that as well. Now the markets are getting a new exchange-traded fund strategy aimed at tracking the...
Published:
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks....
Published:
ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more radical efforts to increase their total return for shareholders. Some may go...
Published:
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top...
Published:
Last Updated:
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Published:
Last Updated:
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
Published:
Last Updated: